AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Learn various ways to stretch your credit card points for travel, ensuring you get the most out of your rewards.
18,785 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Investors face a clear choice between two CRM juggernauts. This guide breaks down HubSpot and Salesforce, weighing gr...
As July nears, chatter over SpaceX joining the Nasdaq-100 swirls. This article argues that a bigger, more reliable ca...
New Hampshire's Executive Council rejected a proposed $100 million Bitcoin-backed municipal bond in a 3-2 vote, halti...
A Fulton Financial director sold shares after the stock surged about 26%. This article breaks down what insider sales...
A Midtown building collapse is being linked to contractor error in a 1,600-unit office-to-residential conversion, fue...
The Supreme Court struck down a key part of the Trump tariffs, but questions remain for importers about refunds and h...
Investors are torn over a high-growth AI stock. This article breaks down the split, lays out the bull case, and shows...
A new study from Engel & Volkers tracks how the next generation of high-earning buyers is overturning luxury home tre...
A major insider sale at LegalZoom prompts questions for investors. This guide breaks down what the move could mean, h...
Markets staged a broad reversal as crude collapsed and investors priced in a potential de-escalation in a tense geopo...
As aging-in-place renovations gain momentum, Block Renovation’s Julie Kheyfets outlines how ADUs and revised financin...